As of 2025-02-19, the Relative Valuation of Fate Therapeutics Inc (FATE) is (43.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.53 USD, the upside of Fate Therapeutics Inc based on Relative Valuation is -2923.0%.
The range of the Relative Valuation is (33.02) - (50.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 18.8x - 38.4x | 28.6x |
Forward P/E multiples | 21.1x - 32.1x | 26.6x |
Fair Price | (33.02) - (50.23) | (43.19) |
Upside | -2258.2% - -3383.3% | -2923.0% |
Date | P/E |
2025-02-14 | -0.91 |
2025-02-13 | -0.81 |
2025-02-12 | -0.80 |
2025-02-11 | -0.77 |
2025-02-10 | -0.80 |
2025-02-07 | -0.81 |
2025-02-06 | -0.89 |
2025-02-05 | -0.91 |
2025-02-04 | -0.84 |
2025-02-03 | -0.81 |
2025-01-31 | -0.83 |
2025-01-30 | -0.88 |
2025-01-29 | -0.84 |
2025-01-28 | -0.83 |
2025-01-27 | -0.88 |
2025-01-24 | -0.85 |
2025-01-23 | -0.86 |
2025-01-22 | -0.86 |
2025-01-21 | -0.84 |
2025-01-17 | -0.81 |
2025-01-16 | -0.80 |
2025-01-15 | -0.84 |
2025-01-14 | -0.80 |
2025-01-13 | -0.82 |
2025-01-10 | -0.94 |
2025-01-08 | -1.07 |
2025-01-07 | -1.12 |
2025-01-06 | -1.19 |
2025-01-03 | -1.15 |
2025-01-02 | -1.14 |
2024-12-31 | -1.05 |
2024-12-30 | -1.04 |
2024-12-27 | -1.03 |
2024-12-26 | -1.04 |
2024-12-24 | -1.06 |
2024-12-23 | -1.06 |
2024-12-20 | -1.07 |
2024-12-19 | -1.06 |
2024-12-18 | -1.08 |
2024-12-17 | -1.20 |
2024-12-16 | -1.28 |
2024-12-13 | -1.17 |
2024-12-12 | -1.23 |
2024-12-11 | -1.39 |
2024-12-10 | -1.46 |
2024-12-09 | -1.74 |
2024-12-06 | -1.69 |
2024-12-05 | -1.52 |
2024-12-04 | -1.64 |
2024-12-03 | -1.68 |